Trial intelligence / Profile preview

Staccato alprazolam for prolonged stereotypical seizures

jRCT2061210059Recruiting

Sponsor
UCB
Start
Dec 2021
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in epilepsy comparing Staccato alprazolam arm with Placebo arm (2 arms). Primary endpoints: Treatment success for the treated seizure within 90 seconds after investigational medicinal product administration and Treatment success for the treated seizure with no recurrence after 2 hours. Started Dec 2021; status: recruiting.

02

Drugs

alprazolam
03

Conditions

epilepsy

Beyond the preview

Go deeper on jRCT2061210059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2061210059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call